Medicaid AMP Final Rule Not Expected Until 2013, CMS Official Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Pharmaceutical industry stakeholders could have to wait another year before Medicaid details how to calculate average manufacturer prices for drugs and drug rebates and how to handle other complex issues from the Affordable Care Act.